Tim Lowery Appointed Interim CEO of KBI and Selexis
Information
Tim Lowery, President of JSR Life Sciences, has been named as interim CEO to two of our core group of companies, KBI Biopharma, Inc. and Selexis S.A. A search for a permanent CEO is underway.
For details, please see the announcement from JSR Life Sciences LLC.
https://news.jsrlifesciences.com/220103-tim-lowery-appointed-interim-ceo-of-kbi-and-selexis